Conference Publication: A Novel Pseudomonas aeruginosa Virulence Factor Predicts CLAD and Death after Lung Transplantation
Divithotawela, C., Pham, A., Ledger, E. L., Hopkins, P., Tan, M., Yerkovich, S., Wells, T. J. and Chambers, D. C. (2020). A Novel Pseudomonas aeruginosa Virulence Factor Predicts CLAD and Death after Lung Transplantation. 40th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), Montreal, Canada, 22-25 April 2020. New York, NY United States: Elsevier.
Journal Article: Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies
Divithotawela, Chandima, Pham, Amy, Ledger, Emma L., Hopkins, Peter, Wells, Timothy J. and Chambers, Daniel (2020). Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies. Journal of Heart and Lung Transplantation, 39 (1), 87-89. doi: 10.1016/j.healun.2019.10.001
Evaluation of plasmapheresis to treat intractable lung infections in people with cystic fibrosis
(2024–2025) Cystic Fibrosis Research Limited
Understanding and counteracting antibody-mediated inflammation driving lung damage
(2023–2024) Conquer Cystic Fibrosis Lung Health Transplant Grant
(2020–2022) Prince Charles Hospital Foundation
Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies
Divithotawela, Chandima, Pham, Amy, Ledger, Emma L., Hopkins, Peter, Wells, Timothy J. and Chambers, Daniel (2020). Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies. Journal of Heart and Lung Transplantation, 39 (1), 87-89. doi: 10.1016/j.healun.2019.10.001
A Novel Pseudomonas aeruginosa Virulence Factor Predicts CLAD and Death after Lung Transplantation
Divithotawela, C., Pham, A., Ledger, E. L., Hopkins, P., Tan, M., Yerkovich, S., Wells, T. J. and Chambers, D. C. (2020). A Novel Pseudomonas aeruginosa Virulence Factor Predicts CLAD and Death after Lung Transplantation. 40th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), Montreal, Canada, 22-25 April 2020. New York, NY United States: Elsevier.
Evaluation of plasmapheresis to treat intractable lung infections in people with cystic fibrosis
(2024–2025) Cystic Fibrosis Research Limited
Understanding and counteracting antibody-mediated inflammation driving lung damage
(2023–2024) Conquer Cystic Fibrosis Lung Health Transplant Grant
(2020–2022) Prince Charles Hospital Foundation